The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cellsM.G. Bernengo, Maria Teresa Fierro, Paola Savoia et al.|British Journal of Dermatology|2001Cited by 200
Low-dose intermittent alemtuzumab in the treatment of Sezary syndrome: clinical and immunologic findings in 14 patientsMaria Grazia Bernengo, M. T. Fierro, M. Ortoncelli et al.|Haematologica|2007Cited by 175